- Home
- ALMS vs PACB Comparison
ALMS vs PACB Comparison
Compare ALMS & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- PACB
- Stock Information
- Founded
- ALMS 2021
- PACB 2000
- Country
- ALMS United States
- PACB United States
- Employees
- ALMS N/A
- PACB N/A
- Industry
- ALMS
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- ALMS
- PACB Industrials
- Exchange
- ALMS NYSE
- PACB Nasdaq
- Market Cap
- ALMS 402.6M
- PACB 462.1M
- IPO Year
- ALMS 2024
- PACB 2010
- Fundamental
- Price
- ALMS $4.10
- PACB $1.49
- Analyst Decision
- ALMS Strong Buy
- PACB Buy
- Analyst Count
- ALMS 6
- PACB 9
- Target Price
- ALMS $19.80
- PACB $2.06
- AVG Volume (30 Days)
- ALMS 692.8K
- PACB 7.9M
- Earning Date
- ALMS 08-12-2025
- PACB 08-07-2025
- Dividend Yield
- ALMS N/A
- PACB N/A
- EPS Growth
- ALMS N/A
- PACB N/A
- EPS
- ALMS N/A
- PACB N/A
- Revenue
- ALMS $17,389,000.00
- PACB $152,357,000.00
- Revenue This Year
- ALMS N/A
- PACB $3.33
- Revenue Next Year
- ALMS N/A
- PACB $17.88
- P/E Ratio
- ALMS N/A
- PACB N/A
- Revenue Growth
- ALMS N/A
- PACB N/A
- 52 Week Low
- ALMS $2.76
- PACB $0.85
- 52 Week High
- ALMS $13.20
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- PACB 52.55
- Support Level
- ALMS N/A
- PACB $1.50
- Resistance Level
- ALMS N/A
- PACB $1.69
- Average True Range (ATR)
- ALMS 0.00
- PACB 0.13
- MACD
- ALMS 0.00
- PACB -0.01
- Stochastic Oscillator
- ALMS 0.00
- PACB 34.15
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.